Repositorio Institucional de la Universidad Alfonso X el Sabio

Stem Cell Therapy: A Compassionate Use Program in Perianal Fistula

Mostrar el registro sencillo del ítem

APA

Herreros, M. D. & Garcia Olmo, D. & Guadalajara, H. & Georgiev Hristov, Tihomir & Brandariz, L. & Garcia Arranz, M. (2019-05 ) .Stem Cell Therapy: A Compassionate Use Program in Perianal Fistula.

ISO 690

Herreros, M. D. & Garcia Olmo, D. & Guadalajara, H. & Georgiev Hristov, Tihomir & Brandariz, L. & Garcia Arranz, M.. 2019-05 .Stem Cell Therapy: A Compassionate Use Program in Perianal Fistula.

https://hdl.handle.net/20.500.12080/39462
dc.contributor.author Herreros, M. D.
dc.contributor.author Garcia Olmo, D.
dc.contributor.author Guadalajara, H.
dc.contributor.author Georgiev Hristov, Tihomir
dc.contributor.author Brandariz, L.
dc.contributor.author Garcia Arranz, M.
dc.date.accessioned 2024-02-01T17:34:34Z
dc.date.available 2024-02-01T17:34:34Z
dc.date.created 2019-05
dc.date.issued 2019-05
dc.identifier.uri https://hdl.handle.net/20.500.12080/39462
dc.description.abstract Aim. To report our experience in a compassionate use program for complex perianal fistula. Methods. Under controlled circumstances and approved by European and Spanish laws, a compassionate use program allows the use of stem cell therapy for patients with nonhealing diseases, mostly complex fistula-in-ano, who do not meet criteria to be included in a clinical trial. Candidates had previously undergone multiple surgical interventions that had failed. The intervention consisted of surgery (with closure of the internal opening or a surgical flap performance), followed by stem cell injection. Three types of cells were used for implant: stromal vascular fraction, autologous expanded adipose-derived, or allogenic adipose-derived stem cells. Healing was evaluated at 6th month follow-up. Outcome was classified as partial response or healing. Relapse was evaluated 1 year later. Maximum follow-up period was 48 months. Results. 45 patients (24 male) were included; the mean age was 45 years, which ranged from 24 to 69 years. Since some of them received repeated doses, 52 cases were considered (42 fistula-in-ano, 7 rectovaginal fistulas, 1 urethrorectal fistula, 1 sacral fistula, and 1 hidradenitis suppurativa). Regarding fistula-in-ano, there were 18 Crohn¿s-associated and 24 cryptoglandular. 49 cases (94.2%) showed partial response starting 6.5 weeks of follow-up. 24 cases (46.2%) healed in a mean time of 5.5 months. A year later, all patients cured remained healed. No adverse effects related to stem cell therapy were reported. Conclusion. Stem cells are safe and useful for treating anal fistulae. Healing can be achieved in severe cases es_ES
dc.format application/pdf es_ES
dc.language eng es_ES
dc.rights CC-BY es_ES
dc.rights.uri http://creativecommons.org/licenses/by/4.0/deed.es es_ES
dc.title Stem Cell Therapy: A Compassionate Use Program in Perianal Fistula es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.rights.accessrights info:eu-repo/semantics/openAccess es_ES
dc.identifier.location N/A es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

CC-BY Excepto si se señala otra cosa, la licencia del ítem se describe como CC-BY

Buscar en DSpace


Listar

Mi cuenta

Social Media